1H MR spectroscopy of inflammation, infection and ischemia of the brain

European Journal of Radiology

Volumn 67, Issue 2, 2008, Pages 250-257

  Mader, Irina ^a   Rauer, Sebastian ^a   Gall, Peter ^a   Klose, Uwe ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b the CNS   (Germany)

Author keywords

Bacterial abscesses; Brain ischemia; Demyelination; MR spectroscopy; Review; Viral disease

Indexed keywords

MULTIPLE SCLEROSIS (MS);

MICROFLUIDICS;

AMINO ACID; ANTIRETROVIRUS AGENT; CHOLINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ARTICLE; BACTERIAL INFECTION; BRAIN ABSCESS; BRAIN INFARCTION SIZE; BRAIN INFECTION; BRAIN ISCHEMIA; DEMYELINATION; DIFFUSION WEIGHTED IMAGING; ENCEPHALITIS; ENCEPHALOMYELITIS; GLIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE SCLEROSIS; PERFUSION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REMYELINIZATION; STROKE; VIRUS INFECTION; WHITE MATTER;

BRAIN CHEMISTRY; BRAIN DISEASES; BRAIN ISCHEMIA; HUMANS; INFECTION; INFLAMMATION; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 46749114788     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.02.033     Document Type: Article

References (72)

1. Barker P.B., Gillard J.H., van Zijl P.C., et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 192 (1994) 723-732
2. Gideon P., Henriksen O., Sperling B., et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 23 (1992) 1566-1572
3. Graham G.D., Blamire A.M., Rothman D.L., et al. Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke 24 (1993) 1891-1896
4. Mader I., Roser W., Kappos L., et al. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 21 (2000) 1220-1227
5. Matthews P.M., and Arnold D.L. Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution. Curr Opin Neurol 14 (2001) 279-287
6. Nicoli F., Lefur Y., Denis B., et al. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke 34 (2003) e82-e87
7. Roser W., Hagberg G., Mader I., et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 33 (1995) 811-817
8. Glodzik-Sobanska L., Li J., Mosconi L., et al. Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. AJNR Am J Neuroradiol 28 (2007) 470-474
9. De Stefano N., Matthews P.M., Narayanan S., et al. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 49 (1997) 1138-1141
10. De Stefano N., Narayanan S., Francis S.J., et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 59 (2002) 1565-1571
11. De Stefano N., Narayanan S., Matthews P.M., et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 122 (1999) 1933-1939
12. Chang L., Ernst T., Leonido-Yee M., et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53 (1999) 782-789
13. Kinoshita Y., and Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10 (1997) 2-12
14. Rumpel H., Khoo J.B., Chang H.M., et al. Correlation of the apparent diffusion coefficient and the creatine level in early ischemic stroke: a comparison of different patterns by magnetic resonance. J Magn Reson Imag 13 (2001) 335-343
15. Stadlbauer A., Gruber S., Nimsky C., et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238 (2006) 958-969
16. Pan J.W., Hetherington H.P., Vaughan J.T., et al. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 36 (1996) 72-77
17. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993) 981-989
18. Bluml S., Seymour K.J., and Ross B.D. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med 42 (1999) 643-654
19. Chang L., Ernst T., Leonido-Yee M., et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52 (1999) 100-108
20. Samann P.G., Schlegel J., Muller G., et al. Serial proton MR spectroscopy and diffusion imaging findings in HIV-related herpes simplex encephalitis. AJNR Am J Neuroradiol 24 (2003) 2015-2019
21. Bitsch A., Schuchardt J., Bunkowski S., et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 (2000) 1174-1183
22. Brand A., Richter-Landsberg C., and Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15 (1993) 289-298
23. Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., and Koralnik I.J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 63 (2004) 897-900
24. Cianfoni A., Niku S., and Imbesi S.G. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 28 (2007) 272-277
25. Sastre-Garriga J., Ingle G.T., Chard D.T., et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 62 (2005) 569-573
26. Parsons M.W., Li T., Barber P.A., et al. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 55 (2000) 498-505
27. Arnold D.L., Matthews P.M., Francis G.S., et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 31 (1992) 235-241
28. Mader I., Seeger U., Weissert R., et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. Brain 124 (2001) 953-961
29. Lewiston N.J., Theodore J., and Robin E.D. Intracellular edema and dehydration: effects on energy metabolism in alveolar macrophages. Science 191 (1976) 403-404
30. Behar K.L., and Ogino T. Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Magn Reson Med 30 (1993) 38-44
31. Hofmann L., Slotboom J., Boesch C., and Kreis R. Characterization of the macromolecule baseline in localized (1)H-MR spectra of human brain. Magn Reson Med 46 (2001) 855-863
32. Hwang J.H., Graham G.D., Behar K.L., et al. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 35 (1996) 633-639
33. Pfeuffer J., Tkac I., Provencher S.W., and Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson 141 (1999) 104-120
34. Seeger U., Klose U., Mader I., et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 49 (2003) 19-28
35. Seeger U., Mader I., Nagele T., et al. Reliable detection of macromolecules in single-volume 1H NMR spectra of the human brain. Magn Reson Med 45 (2001) 948-954
36. Soher B.J., Vermathen P., Schuff N., et al. Short TE in vivo (1)H MR spectroscopic imaging at 1.5 T: acquisition and automated spectral analysis. Magn Reson Imag 18 (2000) 1159-1165
37. Gasparovic C., Arfai N., Smid N., and Feeney D.M. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J Neurotrauma 18 (2001) 241-246
38. 2+-modulated lipolysis in neonatal rat brain slices observed by one- and two-dimensional NMR. J Neurochem 71 (1998) 1727-1732
39. Behar K.L., Rothman D.L., Spencer D.D., and Petroff O.A. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 32 (1994) 294-302
40. Demaerel P., Van Hecke P., Van Oostende S., et al. Bacterial metabolism shown by magnetic resonance spectroscopy. Lancet 344 (1994) 1234-1235
41. Hajek M., and Dezortova M. Introduction to clinical in vivo MR spectroscopy. Eur J Radiol 67 (2008) 185-193
42. Helms G. The principles of quantification applied to in vivo 1H MR spectroscopy. Eur J Radiol 67 (2008) 218-229
43. Jiru F. Introduction to post-processing techniques. Eur J Radiol 67 (2008) 202-217
44. Klose U. Measurement sequences for single voxel 1H MR spectroscopy. Eur J Radiol 67 (2008) 194-201
45. Hanstock C.C., Cwik V.A., and Martin W.R. Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis. J Neurol Sci 198 (2002) 37-41
46. Wang Y., and Li S.J. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 39 (1998) 28-33
47. Arnold D.L. Evidence for neuroprotection and remyelination using imaging techniques. Neurology 68 (2007) S83-S90 discussion S91-96
48. Trapp B.D., Ransohoff R., and Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 12 (1999) 295-302
49. Tartaglia M.C., Narayanan S., De Stefano N., et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 249 (2002) 1382-1390
50. Davie C.A., Hawkins C.P., Barker G.J., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117 (1994) 49-58
51. De Stefano N., Matthews P.M., Fu L., et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121 (1998) 1469-1477
52. Schubert F., Seifert F., Elster C., et al. Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations. Magma 14 (2002) 213-222
53. Davie C.A., Barker G.J., Webb S., et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118 (1995) 1583-1592
54. Sarchielli P., Presciutti O., Tarducci R., et al. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. J Neurol Neurosurg Psychiatry 64 (1998) 204-212
55. Husted C.A., Goodin D.S., Hugg J.W., et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 36 (1994) 157-165
56. Kapeller P., McLean M.A., Griffin C.M., et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 248 (2001) 131-138
57. Chard D.T., Griffin C.M., McLean M.A., et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 125 (2002) 2342-2352
58. Salvan A.M., Vion-Dury J., Confort-Gouny S., et al. Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses 13 (1997) 1055-1066
59. Taylor M.J., Schweinsburg B.C., Alhassoon O.M., et al. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol 13 (2007) 150-159
60. Aydin K., Tatli B., Ozkan M., et al. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS. Neurology 67 (2006) 911-913
61. Callot V.G.D., Le Fur Y., Confort-Gouny S., Ranjeva J.P., and Cozzone P.J. Spectroscopy of human brain tumours: a practical approach. Eur J Radiol 67 (2008) 268-274
62. Dev R., Gupta R.K., Poptani H., et al. Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses. Neurosurgery 42 (1998) 37-42 discussion 42-33
63. Garg M., Gupta R.K., Husain M., et al. Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 230 (2004) 519-527
64. Grand S., Passaro G., Ziegler A., et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy-initial results. Radiology 213 (1999) 785-793
65. Harada M., Tanouchi M., Miyoshi H., et al. Brain abscess observed by localized proton magnetic resonance spectroscopy. Magn Reson Imag 12 (1994) 1269-1274
66. Kim S.H., Chang K.H., Song I.C., et al. Brain abscess and brain tumor: discrimination with in vivo H-1 MR spectroscopy. Radiology 204 (1997) 239-245
67. Poptani H., Gupta R.K., Jain V.K., et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imag 13 (1995) 1019-1029
68. Gupta R.K., Vatsal D.K., Husain N., et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 22 (2001) 1503-1509
69. Pretell E.J., Martinot Jr. C., Garcia H.H., et al. Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr 29 (2005) 112-114
70. Omuro A.M., Leite C.C., Mokhtari K., and Delattre J.Y. Pitfalls in the diagnosis of brain tumours. Lancet Neurol 5 (2006) 937-948
71. Graham G.D., Blamire A.M., Howseman A.M., et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23 (1992) 333-340
72. Fiehler J. Editorial comment-ADC and metabolites in stroke: even more confusion about diffusion?. Stroke 34 (2003) e87-e88